Minimally invasive management of achalasia cardia: results from a single center study

C Palanivelu1, G S Maheshkumar, Kalpesh Jani

  • 1Department of GI & Minimal Access Surgery, Gem Hospital, Pankaja Mill Road, Ramanathapuram, Coimbatore-641045, Tamilnadu, India.

Insights

Laparoscopic cardiomyotomy is a safe and effective treatment for achalasia cardia, with Toupet's fundoplication showing excellent results in 226 patients. This minimally invasive approach significantly improved dysphagia symptoms.

Area of Science:

  • Gastroenterology
  • Minimally Invasive Surgery
  • Surgical Oncology

Background:

  • Laparoscopic cardiomyotomy has gained popularity for treating achalasia cardia since its introduction in 1991.
  • This study reviews the experience of 226 patients who underwent the procedure.

Purpose of the Study:

  • To evaluate the safety and efficacy of laparoscopic cardiomyotomy for achalasia cardia.
  • To discuss relevant surgical and management issues.

Main Methods:

  • Retrospective analysis of 226 patients who underwent laparoscopic cardiomyotomy since 1993.
  • Detailed description of preoperative workup, surgical technique (myotomy alone, Dor's, or Toupet's fundoplication), and postoperative management.

Main Results:

  • The study included 146 males and 80 females, with a mean age of 36.4 years.
  • Dysphagia was eliminated in 88.9% of patients, with an overall morbidity of 4.4% and no mortality.
  • Mean follow-up was 4.3 years; 162 patients had Toupet's fundoplication, while 44 had Dor's fundoplication.

Conclusions:

  • Laparoscopic cardiomyotomy, particularly with Toupet's fundoplication, is a safe and effective treatment for achalasia cardia.
  • Dor's fundoplication is reserved for cases with suspected mucosal injury.
Abstract

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...